Kuramochi M, Seki H, Tazawa T, Sakai S, Sakai Y
Biomedical Laboratories Inc., Saitama, Japan.
Mutat Res. 1992 Feb-Mar;278(2-3):121-5.
The micronucleus test using mouse peripheral blood was conducted with N-methyl-N'-nitro-N-nitro-soguanidine (MNNG) and mitomycin C (MMC) as part of the 5th collaborative study supported by the Environmental Mutagen Society of Japan (CSGMT/MMS.JEMS). Male CD-1 mice were intraperitoneally injected once with 12.5-100 mg/kg of MMC. Peripheral blood was drawn at different intervals after treatment, placed on slides previously coated with acridine orange and the numbers of reticulocytes with micronuclei (MNRETs) were scored. The experiments indicated that the maximum effect of both MNNG and MMC was found about 48 h after treatment, and that the micronucleus test using peripheral blood is useful for the screening of chemicals throughout the experimental period in a single animal.
作为日本环境诱变剂学会支持的第五次合作研究(CSGMT/MMS.JEMS)的一部分,使用小鼠外周血进行了微核试验,以N-甲基-N'-硝基-N-亚硝基胍(MNNG)和丝裂霉素C(MMC)作为受试物。雄性CD-1小鼠腹腔注射一次12.5-100mg/kg的MMC。在处理后的不同时间间隔采集外周血,置于预先涂有吖啶橙的载玻片上,对含微核的网织红细胞(MNRETs)数量进行计数。实验表明,MNNG和MMC的最大效应在处理后约48小时出现,并且使用外周血进行微核试验对于在单个动物的整个实验期内筛选化学物质是有用的。